Publikationsserver der Universitätsbibliothek Marburg

Titel:lin-Benzopurines as Inhibitors of tRNA-Guanine Transglycosylase: Perturbance of Homodimer Formation, Import of Water Clusters and Determinants of Crystallographical Disorder
Autor:Immekus, Florian Peter Philip
Weitere Beteiligte: Klebe, Gerhard (Prof. Dr.)
URN: urn:nbn:de:hebis:04-z2013-00742
DDC: Naturwissenschaften
Titel (trans.):lin-Benzopurine als Inhibitoren der tRNA-Guanin Transglycosylase: Störung der Homodimer Formation, Import von Wassernetzwerken und Determinanten kristallographischer Unordnung


water cluster analysis, Proteinkristallographie, protein protein interaction, inhibitor design, Enzyminhibitor, Inhibitordesign, Queuin-tRNS-Ribosyltransferase, Protein Protein Interaktion, Wassernetzwerkanalyse
Referenziert von:

In this thesis different methods of structure-based drug design have been applied to develop TGT inhibitors suiting the manifold purposes of the tackled projects. TGT is not only a putative target for the treatment of Shigellosis, but additionally represents a well-accessible model system to study more general aspects of drug design. The presented results are mostly received from X-ray crystallography and binding affinity measurements. For the latter determinations, a new method - microscale thermophoresis - has been introduced. To characterize binding of TGT ligands, the newly established protocol largely replaces the expensive and time-consuming kinetic assay based on radioactive labeled guanine. The experimental perspective has been further expanded by a point mutation study, methods of computational chemistry and non-covalent nanoESI mass spectrometry. The latter technique provided crucial information about the dimer stability of TGT in solution and upon the impact of ligands, designed to perturb the anticipated hot spot interactions of the dimer interface (section 2). For the first time, a dimer destabilization in solution has been verified induced by needle-type decorated ligands which spike into the interface region. However, these ligands were not able to fully disrupt the dimer which questions the importance of the targeted substructures for dimer stability. A detailed crystal structure analysis of three TGT-ligand complexes complemented with collected affinity data could unravel the role of the targeted helix-loop-substructure, assumed to be crucial for dimer stability due to preceding mutation studies. Despite the involvement of this substructure in several, crystallographically conserved directed interactions between the monomer mates this helix-loop-motif is most likely flexible in solution and just conveyed into a well-ordered arrangement upon crystallization. Supported by molecular modeling and MD-simulations it was possible to provide an explanation for the discrepancy between the discovered minor importance of these helix-loop associated directed interactions and the observed ligand-induced dimer destabilization in solution. In section 3 two series of TGT inhibitors have been developed - each corresponding to another variation of the lin-benzoguanine scaffold. The lin-benzohypoxanthines - lacking the exocyclic amino function at C(6) - and the C(6)-N-alkylated lin-benzoguanines have been analyzed with respect to their membrane permeability, pKa-profile, binding mode in crystal structures and binding affinity. Finally these characteristics have been compared to the parental lin-benzoguanines studied in previous works. For the pyrimidine portion of lin-benzohypoxanthines a shift of ca. two pKa units to increased acidity could be achieved compared to the analog lin-benzoguanines. However, despite the reduced tendency to be charged, lin-benzohypoxanthines showed no improved membrane permeability. The lin-benzohypoxanthines exhibit strongly reduced binding affinities in the micromolar range which could be reasoned by the loss of two H-bonds formed between the exocyclic amino function of parental lin-benzoguanines and two aspartates of the binding pocket. A water cluster was identified as a crystallographically conserved arrangement being picked up upon binding of lin-benzohypoxanthines. This cluster experiences several favorable interactions to the protein and to the ligand and was partially found also in the apo structure. Despite this water cluster cannot compensate the loss in affinity for lin-benzohypoxanthines, the potential large impact of favorable water-protein interactions on the ligand´s binding affinity could be demonstrated by crystal structure analysis of two C(6)-N-alkylated lin-benzoguanines. In section 4, a series of disubstituted lin-benzoguanines and lin-benzohypoxanthines has been characterized in terms of their binding mode and affinity. The combination of substituents simultaneously targeting the ribose33- and ribose34-pocket yielded the first TGT inhibitor exhibiting picomolar binding affinity. However, the comparison of disubstituted compounds with their monosubstituted analogs revealed that the overall binding affinity is not necessarily improved by sidechain combination to result in additivity of affinity contributions. The results presented in section 2 concerning the flexibility of a dimer interface-associated helix-loop substructure also affect the interpretation of crystal structures in section 4. In section 4, a more rigid, crystallographically defined binding mode within the ribose33-pocket could be obtained for the C(2)-substituents of three compounds of the analyzed series. In section 5, a mutationally introduced asparagine within the TGT recognition pocket can be used as a model for a permanently protonated aspartate, which is involved in ligand binding and catalysis.

Bibliographie / References

  1. Sansonetti, P. J. (2001). III. Shigellosis: from symptoms to molecular pathogenesis. Am J Physiol Gastrointest Liver Physiol 280:G318-323.
  2. Romier, C. (1997). Crystallographic and Mutagenesis Studies of tRNA-Guanine Transglycosylase. Dissertation, Université de la Mediterranée Aix-Marseille II, Marseille (Frankreich)
  3. Wienken, C. J., Baaske, P., Rothbauer, U., Braun, D., Duhr, S. (2010). Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun DOI: 10.1038/ncomms1093
  4. Ritschel, T., Hörtner, S., Heine, A., Diederich, F., Klebe, G. (2009). Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT. ChemBioChem 10, 716-727.
  5. Ritschel, T., Kohler, P. C., Heine, A., Diederich, F., Klebe, G. (2009). How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase. ChemMedChem 4, 2012-2023.
  6. Steuber, H., Heine, A., Klebe, G. (2007). Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution. J. Mol. Biol. 368, 618-638.
  7. Stengl, B., Meyer, E. A., Heine, A., Brenk, R., Diederich, F., Klebe, G. (2007). Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding. J. Mol. Biol. 370, 492-511.
  8. Iwata-Reuyl, D. (2003). Biosynthesis of the 7-deazaguanosine hypermodified nucleosides of transfer RNA. Bioorg Chem 31, 24-43.
  9. Lee, B., Van Lanen, S. G., Iwata-Reuyl, D. (2007). Mechanistic studies of Bacillus subtilis QueF, the nitrile oxidoreductase involved in queuosine biosynthesis. Biochemistry 46, 12844-854.
  10. Xie, W., Liu, X., Huang, R. H. (2003). Chemical trapping and crystal structure of a catalytic tRNA guanine transglycosylase covalent intermediate. Nat. Struct. Biol. 10, 781-788. Curriculum Vitae PERSÖNLICHE DATEN Geburtsdatum/ -ort: 06. Juni 1983 in Lüdenscheid Familienstand: ledig Staatsangehörigkeit: deutsch SCHUL-UND HOCHSCHULBILDUNG Seit 07/2009 Promotion am Institut für Pharmazeutische Chemie der Philipps- Universität Marburg, Arbeitskreis Prof. Dr. Klebe 09/2010 -01/2012
  11. Dorman, C. J., Porter, M. E. (1998). The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanisms. Molecular Microbiology 29, 677-684.
  12. Fiser, A., Sali, A. (2003). ModLoop: automated modeling of loops in protein structures. Bioinformatics 19, 2500-01.
  13. Gong, X., Figus, M., Plewa, J., Levorse, D., Zhou, L.,Welch, C. (2008). Evaluation of Multiplexed CE with UV Detection for Rapid pK a Estimation of Active Pharmaceutical Ingredients. Chromatographia 68, 219-225.
  14. Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011. Euro. Surveill. 16, 19878.
  15. Mercury CSD 2.0 -New Features for the Visualization and Investigation of Crystal Structures. J. Appl. Cryst. 41, 466-470.
  16. Robert-Koch-Institut (2011). Abschliesende Darstellung und Bewertung der epidemiologischen Erkenntnisse im EHEC O104:H4 Ausbruch Deutschland 2011.
  17. Leonard, N. J., Kaźmierczak, F., Rykowski, A. (1987). A convenient synthesis of lin- benzopurines through a common intermediate. J. Org. Chem. 52, 2933-2935.
  18. Ritschel, T., Atmanene, C., Reuter, K., Van Dorsselaer, A., Sanglier-Cianferani, S., Klebe, G. (2009). An integrative approach combining noncovalent mass spectrometry, enzyme kinetics and X-ray crystallography to decipher Tgt protein-protein and protein-RNA interaction. J. Mol. Biol. 393, 833-847.
  19. Sack, R. B., Rahman, M., Yunus, M., & Khan, E. H. (1997). Antimicrobial resistancein organisms causing diarrheal disease. Clin Infect Dis 24 Suppl 1, pp 102-105.
  20. Escobar-Páramo, P., Clermont, O., Blanc-Potard, A. B., Bui, H., Le Bouguénec, C., Denamur, E. (2004). A Specific Genetic Background Is Required forAcquisition and Expression of Virulence Factors in Escherichia coli. Molecular Biology and Evolution 21, 1085-1094.
  21. Assay development and characterisation of the recombinant enzyme. J Biol Chem 278, 10491-499.
  22. Nakanishi, S., Ueda, T., Hori, H., Yamazaki, N., Okada, N., Watanabe, K. (1994). A UGU sequence in the anticodon loop is a minimum requirement for recognition by Escherichia coli tRNA-guanine transglycosylase. J Biol Chem 269, 32221- 25.
  23. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse- Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nigles, M., Pannu, N. S., Read, R. J., Rice, L.M., Simonson, T., Warren, G. L. (1998). Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallographica Section D 54, 905-921.
  24. McCarthy, R. M., Somogyi, A., Bandarian, V. (2009). Escherichia coli QueD is a 6- carboxy-5,6,7,8-tetrahydropterin synthase. Biochemistry 48, 2301-2303.
  25. Factorizing selectivity determinants of inhibitor binding toward aldose and aldehyde reductases: structural and thermodynamic properties of the aldose reductase mutant Leu300Pro-fidarestat complex. J. Med. Chem. 48, 5659-5665.
  26. Neudert, G., Klebe, G. (2011). fconv: Format conversion, manipulation and feature computation of molecular data. Bioinformatics 27, 1021-1022.
  27. Dvořáková, H., Holý, A., Masojídková, M. (1988). Fluorescent analogues of acyclic inhibitors of S-adenosyl-L-homocysteine hydrolase. Collect. Czech. Chem. Commun. 53, 1779-1794.
  28. Kohler, P. C., Ritschel, T., Schweizer, W. B., Klebe, G., Diederich, F. (2009). High- affinity inhibitors of tRNA-guanine transglycosylase replacing the function of a structural water cluster. Chem. Eur. J. 15, 10809-10817.
  29. a] Values in parenthesis are statistics for the highest resolution shell. [b] R(I) sym =[∑ h ∑ i |I i (h)-‹I(h)›| / ∑ h ∑ i I i (h)] @BULLET 100, where ‹I(h)› is the mean of the I(h) observation of reflection h. [c] R work = ∑ hkl | F o – F c | / ∑ hkl | F o | . [d] R free was calculated as shown for R work but on refinement-excluded 5% of data.
  30. Moreira, I. S., Fernandes, P. A., Ramos, M. J. (2007). Hot spots -a review of the protein-protein interface determinant amino-acid residues. Proteins 68, 803-812.
  31. Porter, M. A., Hall, J. R., Locke, J. C., Jensen, J. H., Molina, P. A. (2006). Hydrogen bonding is the prime determinant of carboxyl pKa values at the N-termini of alpha-helices. Proteins 63, 621-635.
  32. Branden, C., Tooze, J. (1991). Introduction to Protein Structure, Garland Publishing, Inc., New York Brenk, R., Stubbs, M.T., Heine, A., Reuter, K., Klebe, G. (2003). Flexible adaptations in the structure of the tRNA-modifying enzyme tRNA-guanine transglycosylase and their implications for substrate selectivity, reaction mechanism and structure-based drug design. ChemBioChem 4, 1066-1077.
  33. Okada, N., Nishimura, S. (1979). Isolation and characterization of a guanine insertion enzyme, a specific tRNA transglycosylase, from Escherichia coli. J Biol Chem 254, 3061-3066.
  34. Ligand binding stepwise disrupts water network in thrombin: Enthalpic and entropic changes reveal classical hydrophobic effect. J Med Chem 55(13), 6094- 6110.
  35. Stengl, B., Reuter, K., Klebe, G. (2005). Mechanism and substrate specificity of tRNAguanine transglycosylases (TGTs): tRNA-modifying enzymes from the three different kingdoms of life share a common catalytic mechanism. Chembiochem 6, 1926-1939.
  36. Hof, H., Dörries, R. (2005). Medizinische Mikrobiologie, 3. Auflage, Thieme Verlag, Weinheim Hol, W. G. J. (1985). The role of the alpha-helix dipole in protein function and structure. Prog. Biophys. molec. Biol. 45, 149-195.
  37. Sambrook, J., Fritsch, E. F., Maniatis, T. (1989). Molecular Cloning -A Laboratory Manual, Second Edition. Cold Spring Harbor Laboratory Press.
  38. Ellermann, M., Jakob-Roetne, R., Lerner, C., Borroni, E., Schlatter, D., Roth, D., Ehler, A., Rudolph, M. G., Diederich, F. (2009). Molecular recognition at the active site of catechol-o-methyltransferase: energetically favorable replacement of a water molecule imported by a bisubstrate inhibitor. Angew. Chem. Int. Ed. 48, 9092-9096.
  39. Frey, B., McCloskey, J., Kersten, W., Kersten, H. (1988) New function of vitamin B12: cobamide-dependent reduction of epoxyqueuosine to queuosine in tRNAs of Escherichia coli and Salmonella typhimurium. J Bacteriol 170, 2078-2082.
  40. Avdeef, A., Bendels, S., Di, L., Faller, B., Kansy, M., Sugano, K., Yamauchi, Y. (2007). PAMPA-critical factors for better predictions of absorption. J. Pharm. Sci. 96, 2893-2909.
  41. Hörtner, S. R., Ritschel, T., Stengl, B., Kramer, C., Schweizer, W. B., Wagner, B., Kansy, M., Klebe, G., and Diederich, F. (2007). Potent Inhibitors of tRNA- Guanine Transglycosylase, an Enzyme Linked to the Pathogenicity of the Shigella Bacterium: Charge-Assisted Hydrogen Bonding. Angew. Chem. Int.
  42. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26 (2), 283-291.
  43. Romier, C., Ficner, R., Reuter, K., Suck, D. (1996). Purification, crystallization, and pre-liminary x-ray diffraction studies of tRNA-guanine transglycosylase from Zymomonas mobilis. Proteins: Structure, Function, and Genetics 24, 516-519.
  44. Launay, O., Sadorge, C., Jolly, N., Poirier, B., Bechet, S., van der Vliet, D.,Seffer, V., Fenner, N., Dowling, K., Giemza, R., Johnson, J., Ndiaye, A., Vray, M., Sansonetti, P., Morand, P., Poyart, C., Lewis, D., Gougeon, M. L. (2009). Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type- 1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial. Vaccine 27, 1184-91.
  45. Sheldrick, G. M., Schneider, T. R. (1997). SHELXL: high-resolution refinement. Methods Enzymol. 277, 319-343.
  46. Jennison, A. V., Verma, N. K. (2004). Shigella flexneri infection: pathogenesisand vaccine development. FEMS Microbiology Reviews 28, 43-58.
  47. Fernandez, M. I., Sansonetti, P. J. (2003). Shigella interaction with intestinal epithelialcells determines the innate immune response in shigellosis. Int. J. Med. Microbiol. 293, 55-67.
  48. Eldrup, A. B., Allerson, C. R., Bennett, C. F., Bera, S., Bhat, B., Bhat, N., Bosserman, M. R., Brooks, J., Burlein, C., Caroll, S. S., Cook, P. D., Getty, K. L., MacCoss, M., McMasters, D. R., Olsen, D. B., Prakash, T. P., Prhavc, M., Song, Q., Tomassini, J. E., Xia, J. (2004). Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. J. Med. Chem. 47, 2283-2295.
  49. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. J. Med. Chem. 39, 918-928.
  50. Meyer, E. A., Donati, N., Guillot, M., Schweizer, W. B., Diederich, F., Stengl, B., Brenk, R., Reuter, K., and Klebe, G. (2006). Synthesis, Biological Evaluation, and Crystallographic Studies of Extended Guanine-Based (lin-Benzoguanine) Inhibitors for tRNA-Guanine Transglycosylase (TGT). Helv. Chim. Acta 89, 573-597.
  51. Wada, A. (1976). The alpha-helix as an electric macro-dipole. Adv Biophys 9, 1-63.
  52. Allen, F. H. (2002). The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Cryst. B58, 380-388.
  53. McCarthy, R. M., Somogyi, A., Lin, G., Jacobsen, N. E., Bandarian, V. (2009). The deazapurine biosynthetic pathway revealed: in vitro enzymatic synthesis of preQ0 from guanosine 5´-triphosphate in four steps. Biochemistry 48, 3847- 3852.
  54. Lee, B., Richards, F. M. (1971). The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol 55(3), 379-400.
  55. Landschulz, W. H., Johnson, P. F., McKnight, S. L. (1988). The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240(4860), 1759-64.
  56. Curnow, A. W., Garcia, G. A. (1995). tRNA-guanine transglycosylase from Escherichia coli. Minimal tRNA structure and sequence requirements for recognition. J Biol Chem 270, 17264-67.
  57. Durand, J. M., Okada, N., Tobe, T., Watarai, M., Fukuda, I., Suzuki, T., Nakata, N., Komatsu, K., Yoshikawa, C., Sasakawa, C. (1994). vacC, a virulence-associated chromosomal locus of Shigella flexneri, is homologous to tgt, a gene encoding tRNA-guanine transglycosylase (Tgt) of Escherichia coli K-12. J Bacteriol 176, 4627-4634.
  58. Klebe, G. (2009). Wirkstoffdesign, 2. Auflage, Spektrum Akademischer Verlag, Heidelberg.
  59. Verband forschender Arzneimittelhersteller e.V. (2012). Zugelassene gentechnische Arzneimittel in Deutschland. forschung/datenbanken-zu-arzneimitteln/amzulassungen-gentec.html
  60. Aufbaustudium "Intensivkurs Betriebswirtschaftslehre und betriebliches Management" am Institut für Wirtschafts- wissenschaftliche Forschung und Weiterbildung der Fernuniversität Hagen 04/2010 -10/2011 "Zusatzqualifikation im Pharmarecht" an der Forschungsstelle für Pharmarecht der Philipps-Universität Marburg 06/2010 Verleihung des Grades "Diplom-Pharmazeut" an der Naturwissenschaftlichen Fakultät der Martin-Luther-Universität Halle- Wittenberg; Thema der Arbeit: "Klonierung, Expression und positionsgerichtete Mutation von humanem Thrombin" 06/2009 Erteilung der Approbation als Apotheker 10/2003 -04/2008
  61. Berg, T. (2003). Modulation of protein-protein interactions with small organic molecules. Angew. Chem. Int. Ed. 42, 2462-2481.
  62. Forsyth, W. R., Antosiewicz, J. M., Robertson, A. D. (2002). Empirical relationships between protein structure and carboxyl pKa values in proteins. Proteins 48, 388- 403.
  63. Durand, J. M., Dagberg, B., Uhlin, B. E., Björk, G. R. (2000). Transfer RNA modification, temperature and DNA superhelicity have a common target in the regulatory network of the virulence of Shigella flexneri: the expression of the virF gene. Mol. Microbiol. 35, 924-935.
  64. Van Nhieu, G. T., Bourdet-Sicard, R., Duménil, G., Blocker, A., Sansonetti, P. J. (2000). Bacterial signals and cell resonses during Shigella entry into epithelial cells. Cellular Microbiology 2, 187-193.
  65. Leo, A., Hansch, C., Elkins, D. (1971). Partition coefficients and their uses. Chem. Rev. 71, 525-616.
  66. Taylor, E. A., Clinch, K., Kelly, P. M., Li, L., Evans, G. B., Tyler, P. C., Schramm, V. (2007). Acyclic ribooxacarbenium ion mimics as transition state analogues of human and malarial purine nucleoside phosphorylases. J. Am. Chem. Soc. 129, 6984-6985.
  67. Krueger, A. T., Peterson, L. W., Chelliserry, J., Kleinbaum, D. J., Kool, E. T. (2011). Encoding phenotype in bacteria with an alternative genetic set. J. Am. Chem. Soc. 133, 18447-51.
  68. Rotella, D. P., Sun, Z., Zhu, Y., Krupinski, J., Pongrac, R., Seliger, L., Normandin, D., Macor, J. E. (2000). Optimization of substituted N-3-benzylimidazo- quinazolinone sulfonamides as potent and selective PDE5 inhibitors. J. Med. Chem. 43, 5037-5043.
  69. Bruno, I. J., Cole, J. C., Edgington, P. R., Kessler, M., Macrae, C. F., McCabe, P., Pearson, J., Taylor, R. (2002). New software for searching the Cambridge Structural Database and visualizing crystal structures. Acta Cryst. B58, 389–397.
  70. Emsley, P., Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallographica Section D 60, 2126-2132.
  71. Dixon, M. (1953). The determination of enzyme inhibitor constants. Biochem. J. 55 (1), 170-171.
  72. Reuter, K., Ficner, R. (1995). Sequence analysis and overexpression of the Zymomonas mobilis tgt gene encoding tRNA-guanine transglycosylase: purification and biochemical characterization of the enzyme. J. Bacteriol. 177, 5284-5288.
  73. Durand, J. M., Bjork, G. R., Kuwae, A., Yoshikawa, M., Sasakawa, C. (1997). The modified nucleoside 2-methylthio-N6-isopentenyladenosine in tRNA of Shigella flexneri is required for expression of virulence genes. J Bacteriol 179, 5777- 5782.
  74. Fiser, A., Do, R.K.G., Sali, A. (2000). Modeling of loops in protein structures. Prot Sci 9, 1753-1773.
  75. Kotloff, K., Winickoff, J., Ivanoff, B., Clemens, J., Swerdlow, D., Sansonetti, P. (1999). Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. W.H.O. 651-666.
  76. Phillips, G., Yacoubi, B. E., Lyons, B., Alvarez, S., Iwata-Reuyl, D., et al. (2008). Biosynthesis of 7-deazaguanosine-modified tRNA nucleosides: a new role for GTP cyclohydrolase I. J Bacteriol 190, 7876-7884.
  77. McMillan, K., Adler, M., Auld, D., Baldwin, J., Blasko, E., Browne, L., Chelsky, D., Davey, D., Dolle, R., Eagen, K., Erickson, S., Feldmani, R., Glaser, C., Mallari, C., Morrissey, M., Ohlmeyer, M., Pan, G., Parkinson, J., Phillips, G., Polokoff, M., Sigal, N., Vergona, R., Whitlow, M., Young, T., Devlin, J. (2000). Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. PNAS 97, 1506-1511.
  78. Romier, C., Reuter, K., Suck, D., Ficner, R. (1996). Crystal structure of tRNA-guanine transglycosylase: RNA modification by base exchange. Embo J 15, 2850-2857.
  79. Eisenberg, D., Schwarz, E., Komarony, M., Wall, R. (1984). Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol 179, 125-142.
  80. Grädler, U., Gerber, H.-D., Goodenough-Lashua, D. M., Garcia, G. A., Ficner, R., Reuter, K., Stubbs, M. T., Klebe, G. (2001). A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase. J. Mol. Biol. 306, 455-467.
  81. Case, D.A., Darden, T.A., Cheatham, T.E., Simmerling, C.L., Wang, J., Duke, R.E., Luo, R., Walker, R.C., Zhang, W., Merz, K.M., Roberts, B., Hayik, S., Roitberg, A., Seabra, G., Swails, J., Goetz, A.W., Kolossvai, I., Wong, K.F., Paesani, F., Vanicek, J., Wolf, R.M., Liu, J., Wu, X., Brozell, S.R., Steinbrecher, T., Gohlke, H., Cai, Q., Ye, X., Wang, J., Hsieh, M.-J., Cui, G., Roe, D.R., Mathews, D.H., Seetin, M.G., Salomon-Ferrer, R., Sagui, C., Babin, V., Luchko, T., Gusarov, S., Kovalenko, A., Kollman, P.A. (2012). AMBER 12, University of California , San Francisco Chacko, S., Silverton, E., Kam-Morgan, L., Smith-Gill, S., Cohen, G., Davies, D. (1995). Structure of an antibody-lysozyme complex unexpected effect of conservative mutation. J. Mol. Biol 245, 261-274.
  82. Bogan, A. A., Thorn, K. S. (1998). Anatomy of hot spots in protein interfaces. J. Mol. Biol 280, 1-9.
  83. Clackson, T., Wells, J. A. (1995). A hot spot of binding energy in a hormone-receptor interface. Science 267, 383-386.
  84. Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., Pavletich, N. P. (1996). Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948-953.
  85. Bretner, M., Schalinski, S., Borowski, P., Kulikowski, T. (2003). 5'-O- fluorosulfonylbenzoyl esters of purine nucleosides as potential inhibitors of NTPase/helicase and polymerase of Flaviviridae viruses. Nucleosides, Nucleotides Nucleic Acids 22, 1531-1533.
  86. WHO (2000). The Big Guns of Resistance. In Overcoming Antimicrobial Resistance,Word Health Report on Infectious Diseases. report/ 2000/index.html.

* Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten